Biogen Idec Partners with Isis Pharmaceuticals in $100M Drug Deal

Source: Bloomberg Businessweek

Sep 10, 2013

Biogen Idec Inc., maker of the multiple sclerosis pill Tecfidera, expanded its partnership with Isis Pharmaceuticals Inc. in a deal to develop drugs for neurological disorders. Read the full story